News Feed

Pennington Biomedical Study to Explore Effects of Soy on Blood Sugar Levels
Pennington Biomedical Research Center’s Dr. Candida Rebello wants to know more about the intersection of blood sugar levels and a diet rich in soy. This intersection is the primary focus of her new study, “Lifestyle Intervention for Improving Metabolic and Motivational Outcomes,” or MOTIVATE, which explores how specific diets can impact blood sugar, and potentially improve mood and energy levels.
Learn More
Low Oxygen and Weight Status Trial Seeking Participants
Can reduced oxygen in the air lead to weight loss? That is what Pennington Biomedical researcher Dr. Claire Berryman is exploring in the “Low Oxygen and Weight Status,” or LOWS, study, which is currently recruiting participants. The study is open to adults between the ages of 22 and 65, and it lasts up to four months.
Learn More
Second Annual Louisiana Obesity Society Conference Held in New Orleans
The Louisiana Obesity Society and the Louisiana Chapter of the American Society for Metabolic and Bariatric Surgery hosted the 2024 Louisiana Obesity Conference on Saturday, Aug. 10, in New Orleans at the Renaissance Arts Hotel. Keynote speakers for the event included a video message from Senator Bill Cassidy, MD; State Senator Royce Duplessis; Dr. Jamy Ard, President of The Obesity Society; and Dr. Ann Rogers, President-Elect of the American Society for Metabolic and Bariatric Surgery.
Learn More
Rural Health and Lung Study Coming to Franklin Parish
The Risks Underlying Rural Areas Longitudinal, or RURAL, Heart and Lung study will arrive in Louisiana’s Franklin Parish on Tuesday, Aug. 13. The study team, who were stationed in Assumption Parish starting in February 2024, are conducting a comprehensive longitudinal cohort study designed to help researchers better understand the underlying health risks faced by residents in rural areas.
Learn More
Scientists Reach Consensus for Fasting Terminology
Dr. Eric Ravussin of Pennington Biomedical Research Center in Baton Rouge was one of 38 scientists from five continents to present the first international consensus on fasting terminology and key definitions. Published in Cell Metabolism, the recent study reflects the increasing popularity of diets tied to fasting and a significant increase in scientific studies of fasting. While the application of fasting is rapidly growing, there was previously no globally established terminology.
Learn More
Pennington Biomedical Researcher Dr. Carrie Elks Awarded $1.4 Million to Study Fat Cell Communication Cycle
The National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases, or NIDDK, awarded Pennington Biomedical researcher Dr. Carrie Elks a grant of $1.4 million to explore insulin resistance and inflammation in fat cells. Dr. Elks will apply the grant toward her Matrix Biology Laboratory’s project “Adipocyte cytokine signaling as a coordinator of adipose tissue function.”
Learn More
Reis Alsberry Joins Pennington Biomedical as Director of Intellectual Property and Commercialization
Reis Alsberry has joined the Pennington Biomedical Research Center, serving as the new Director of Intellectual Property and Commercialization. In this role, Reis will oversee the patentability, protection and market potential of inventions and discoveries emerging from Pennington Biomedical. He will also license new technologies to industry through active marketing, and he will help in the creation of startup companies by faculty and students.
Learn More
Pennington Biomedical’s Olympic Debut
If you’ve been keeping up with the summer Olympics in Paris, odds are you’ve also seen a commercial for the Center running during NBC’s coverage. The Comms/Marketing team were able to secure a local commercial spot during this world-wide event in an effort to showcase our great work.
Learn More
Pennington Biomedical Scientists Outline Key Challenges and Promising Avenues in Obesity Genetics
Research on the genetics of obesity dates to the early 1920s, with many of the initial findings indicating the complexity and multifaceted nature of obesity perfectly resonating with more modern discoveries. Researchers at Pennington Biomedical have collected nearly a century’s worth of considerations and advancements to frame their perspectives on modern research into the genetics of obesity.
Learn More
Studying Childhood Obesity: Your Family Could Help Researchers Move Science Forward
Pennington Biomedical Research Center is home to the top scientists in the world who are studying one of the most pressing health issues in our country – childhood obesity. Despite ongoing efforts, childhood obesity rates have continued to soar over the last 10 years, with about 1-in-5 children affected by obesity. To move the science forward, Pennington Biomedical invites parents to enroll their children in clinical research trials.
Learn More
July’s Small Shift: Prioritizing Sleep
Small shifts can make a big impact on a person’s long-term health, and that includes catching some Z's. Quality sleep is essential for physical health, mental clarity and emotional resilience. This month, making a few small adjustments to sleep routines can enhance overall health and energy levels.
Learn More
Celebrate National Blueberry Month with Pennington Biomedical Dietitians
Since 1974, July has been observed as National Blueberry Month in honor of one of nature’s top superfoods. But what exactly makes blueberries so beneficial?
Learn More
The American Cancer Society Awards $217,500 to Pennington Biomedical Researcher for Study on How Aerobic Exercise Impacts Colorectal Cancer Survivors
The American Cancer Society, the largest non-government, non-profit funding source of cancer research in the United States, has approved funding for $28 million in new Extramural Discovery Science research and career development grants. The awards will fund investigators at institutions across the United States starting in July 2024.
Learn More
Pennington Biomedical Research Presented at NUTRITION 2024 in Chicago
NUTRITION 2024, the annual flagship meeting of the American Society of Nutrition, is taking place June 29-July 2 in Chicago, and a number of research findings from the Pennington Biomedical Research Center will be presented during the conference.
Learn More
Louisiana Obesity Society Conference Set for Aug. 10 in New Orleans
The Louisiana Obesity Society and the Louisiana Chapter of the American Society for Metabolic and Bariatric Surgery are happy to announce the 2024 Louisiana Obesity Conference on Saturday, Aug. 10, in New Orleans at the Renaissance Arts Hotel. Keynote speakers for the event are anticipated to include Senator Bill Cassidy, MD; Dr. Jamy Ard, President of The Obesity Society; and Dr. Ann Rogers, President-Elect of the American Society for Metabolic and Bariatric Surgery.
Learn More
New Findings from ARMMS-T2D Study Continue to Show Benefits of Metabolic/Bariatric Surgery Over Medical Interventions for those with Type 2 Diabetes
The 12-year Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes, or ARMMS-T2D, clinical trial continues to provide significant findings on the benefits of bariatric surgery over medical management, as presented during the 84th annual American Diabetes Association Scientific Sessions in Orlando, Fla.
Learn More
Pennington Biomedical Researchers Partner on Award-Winning Long Covid Study
Dr. John Kirwan, Executive Director of Pennington Biomedical Research Center, is serving as a co-principal investigator on the Pathobiology in RECOVER of Metabolic and Immune Systems, or PROMIS, study. The study has been awarded more than $802,000 by the National Institutes of Health to identify potential causes of Long COVID.
Learn More
Pennington Biomedical Research Presented at the 84th Annual American Diabetes Association Scientific Sessions
The 84th annual American Diabetes Association Scientific Sessions are taking place June 21-24 in Orlando, Fla., and several research findings from the Pennington Biomedical Research Center will be presented during the conference.
Learn More
Small Shifts for Nutritional Health
Once a person decides it’s time to lose some weight, it may be difficult to determine what’s the best option for them. With all the diet noise out there, what’s the best way to take off those unwanted pounds—and keep them off?
Learn More
Pre-Operative Use of GLP-1s May Reduce Complications After Metabolic and Bariatric Surgery in Patients with Extreme Obesity
A combination of GLP-1 agonists taken before metabolic and bariatric surgery may help patients with extreme obesity lower the risk of post-operative complications, according to a new study* presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting
Learn More